Humaneered Anti-Factor B Antibody

作者: V. Michael Holers , Peter Flynn , Woodruff Emlen

DOI:

关键词: Complement component 2Complement factor BImmunogenicityAntibodyFactor HAntigenAlternative complement pathwayMurine monoclonal antibodyMolecular biologyBiology

摘要: This invention relates to humaneered anti-factor B antibodies and antigen-binding fragments thereof with reduced immunogenicity. The antigen- binding are derived from murine monoclonal antibody 1379, which binds factor in the third short consensus repeat ('SCR') domain selectively inhibits activation of alternative complement pathway by preventing formation C3bBb complex. also methods treating diseases or disorders plays a role, inhibiting an individual need thereof.

参考文章(225)
De Broe Me, De Backer Wa, Pathophysiology of hemodialysis-associated hypoxemia. Advances in nephrology from the Necker Hospital. ,vol. 18, pp. 297- 315 ,(1989)
Dennis Hourcade, John P. Atkinson, Malgorzata Krych, Cells expressing a modified regulator of complement activation ,(1999)
Yvan Guindon, Joshua Rokach, Cheuk K. Lau, Christiane Yoakim, Rejean Fortin, Method of inhibiting mammalian leukotriene biosynthesis ,(1987)
Charles G. Glabe, Rakez Kayed, Ralf Langen, Volker Luibl, Jeannie Chen, Jose Mario Isas, Compositions and methods for inhibiting drusen formation and for diagnosing or treating drusen-related disorders ,(2006)
Thomas Hebell, Douglas T. Fearon, Soluble complement regulatory molecules ,(1991)